Replies to post #94495 on Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Sorry guys.

Half of the pts showing little change is unimpressive. or maybe you'd like to address the other half that presumably showed no change.

And how can there be a home run for data that has yet to be presented ....

Maybe we can talk about data that counts-how the later cohorts did-when we know more about it.

[frrol]

From what I read in the past two days in this thread, I think Dr. Menon is putting more faith in the p21 as a biomarker (for Kevetrin's activity at least) than some of his professional colleagues now are in general.

btw, I wonder how hard it would be to test for PUMA. Now that there's research showing the PUMA/p21 ratio could be relevant, I'd love it if they tested for PUMA too.

[To infinity and beyond!]

We are just talking past each other.

p21 may well be important. All I meant is that phase 1 so far has yet to demonstrate any big impact